Thurston Springer Miller Herd & Titak’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2	Closed	-$540	–	1642
2025 Q1	$540	Buy	+2	New	+$540	﹤0.01%	1573